BIA-ALCL: Breast Implant-Associated Anaplastic Large Cell Lymphoma-Reference-Cited by-同舟云学术

BIA-ALCL: Breast Implant-Associated Anaplastic Large Cell Lymphoma

Published:2024 Issue: Volume: Page:
ISSN:2731-4561
Container-title:Interdisciplinary Cancer Research
language:
Short-container-title:

Author:

Longo Benedetto,Gagliano Elettra,Giacalone Martina,D’Orsi Gennaro,Vannucchi Lisa,Vanni Gianluca,Buonomo Oreste Claudio,Cervelli Valerio

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/16833_2024_386

Reference48 articles.

1. Allchin RL, Wickenden K, Pilgrim S, Wilson-Morkeh I, Miall FM (2020) The successful use of neo adjuvant Brentuximab Vedotin in the treatment of BIA-ALCL. Hemasphere 4(6):e501. Published 2020 Nov 24. https://doi.org/10.1097/HS9.0000000000000501

2. American Society of Plastic Surgeons (2023) BIA-ALCL physician resources. https://www.plasticsurgery.org/for-medical-professionals/health-policy/bia-alcl-physician-resources. Accessed 2 Oct 2023

3. Campanale A, Lispi L, Iachino A (2022a) An unusual case of BIA-ALCL associated with prolonged/complicated biocell-textured expander, followed by smooth round breast implant exposure, and concurrent use of Adalimumab. Plast Reconstr Surg 150(5):1104e–1105e. https://doi.org/10.1097/PRS.0000000000009578

4. Campanale A, Ventimiglia M, Minella D et al (2022b) National Breast Implant Registry in Italy. Competent authority perspective to improve patients’ safety. PRRS 1:34–45. https://doi.org/10.57604/PRRS-005

5. Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059–3068. https://doi.org/10.1200/JCO.2013.54.8800